Procter & Gamble Health Q2 Results
- BSE: 500126
- NSE: PGHL
- ISIN: INE199A01012
- Sector: Biotechnology & Drugs
BSE
5,285.55
-12.70 (-0.24%)
-12.70 (-0.24%)Volume64.00
Updated: Thu 10 Oct, 2024 | 15:29:36
NSE
5,280.05-25.85 (-0.49%)
-25.85 (-0.49%)Volume2.37 K
Updated: Thu 10 Oct, 2024 | 15:29:37
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Procter & Gamble Health Q2 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp | Dec 22 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 309.97 | 304.93 | -% | 309.97 | -% |
| Selling/ General/ Admin Expenses Total | 57.43 | 60.64 | -% | 47.26 | -% |
| Depreciation/ Amortization | 6.92 | 6.48 | -% | 8.23 | -% |
| Other Operating Expenses Total | 60.50 | 68.49 | -% | 70.91 | -% |
| Total Operating Expense | 215.24 | 222.75 | -% | 209.34 | -% |
| Operating Income | 94.73 | 82.18 | -% | 100.63 | -% |
| Net Income Before Taxes | 99.72 | 88.05 | -% | 104.94 | -% |
| Net Income | 72.07 | 65.57 | -% | 76.80 | -% |
| Diluted Normalized EPS | 43.40 | 39.50 | -% | 46.97 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Garuda Construction and Engineering Limited IPO: GMP, subscription status to review. Buy or not?
4 min read03:20 PM IST - Markets
02Buy or sell: Vaishali Parekh recommends three stocks to buy today — October 10
3 min read06:11 AM IST - Markets
03From ₹11 to ₹164: Penny stock turns multibagger, rises over 1,300% in 4 years
3 min read07:48 AM IST